D. E. Shaw & Co., Inc. Elanco Animal Health Inc Transaction History
D. E. Shaw & Co., Inc.
- $125 Billion
- Q2 2025
A detailed history of D. E. Shaw & Co., Inc. transactions in Elanco Animal Health Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 215,088 shares of ELAN stock, worth $4.54 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
215,088
Previous 383,551
43.92%
Holding current value
$4.54 Million
Previous $4.03 Million
23.74%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding ELAN
# of Institutions
453Shares Held
500MCall Options Held
980KPut Options Held
1.14M-
Dodge & Cox San Francisco, CA82.8MShares$1.75 Billion0.96% of portfolio
-
Primecap Management CO Pasadena, CA50MShares$1.05 Billion0.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.6MShares$1.02 Billion0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD31.5MShares$665 Million0.39% of portfolio
-
Dimensional Fund Advisors LP Austin, TX24.7MShares$521 Million0.11% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $10B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...